Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease

被引:50
|
作者
Lee, E. S. [1 ]
Kim, N. [1 ,2 ,3 ]
Lee, S. H. [1 ]
Park, Y. S. [1 ,2 ,3 ]
Kim, J. W. [1 ]
Jeong, S. H. [1 ]
Lee, D. H. [1 ,2 ,3 ]
Jung, H. C. [2 ,3 ]
Song, I. S. [2 ,3 ]
机构
[1] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Songnam 463707, Gyeonggi Do, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
[3] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea
关键词
GASTROESOPHAGEAL-REFLUX; DOUBLE-BLIND; FOLLOW-UP; CHINESE POPULATION; ON-DEMAND; 40; MG; SYMPTOMS; PREVALENCE; OMEPRAZOLE; LANSOPRAZOLE;
D O I
10.1111/j.1365-2036.2009.04021.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P>Background There has been no report on the response to proton pump inhibitor (PPI) therapy and on-demand or the relapse rate of non-erosive reflux disease (NERD) and erosive oesophagitis in Korea. Aim To compare the risk factors, clinical symptoms and PPI responses between patients with erosive oesophagitis and NERD patients. Methods A survey was performed prospectively in the erosive oesophagitis (205 patients) and NERD group (200 patients). Clinical symptoms, risk factors and PPI responses were analysed. On-demand therapy and the relapse rate of GERD symptoms were investigated during a one-year follow-up. Results BMI >= 25 (OR 3.0, 95% CI 1.1-8.3), alcohol use (OR 2.9, 95% CI 1.0-8.3), hiatal hernia (OR 5.0, 95% CI 1.2-20) and triglyceride >= 150 mg/dL (OR 4.0, 95% CI 1.7-10) were more common in the erosive oesophagitis group than in the NERD group by multivariate analysis. The ratio of oesophageal to extra-oesophageal symptoms was higher in the erosive oesophagitis group compared with the NERD group (P < 0.001). The PPI response rates at 8 weeks were different (P = 0.02); refractory rates were higher in the NERD group (16.7%) compared with the erosive oesophagitis group (6.0%). However, there was no significant difference between the two groups in on-demand therapy or the relapse rate. Conclusion These results suggest that the underlying pathogenic mechanisms of erosive oesophagitis and NERD are distinct.
引用
收藏
页码:154 / 164
页数:11
相关论文
共 50 条
  • [1] Risk factors for proton pump inhibitor refractoriness in Chinese patients with non-erosive reflux disease
    Niu, Xiao-Ping
    Yu, Bao-Ping
    Wang, Yun-Dong
    Han, Zhen
    Liu, Shao-Fen
    He, Chi-Yi
    Zhang, Guo-Zheng
    Wu, Wan-Chun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (20) : 3124 - 3129
  • [2] Risk factors for proton pump inhibitor refractoriness in Chinese patients with non-erosive reflux disease
    Xiao-Ping Niu
    Bao-Ping Yu
    Yun-Dong Wang
    Zhen Han
    Shao-Fen Liu
    Chi-Yi He
    Guo-Zheng Zhang
    Wan-Chun Wu
    World Journal of Gastroenterology, 2013, (20) : 3124 - 3129
  • [3] Dexlansoprazole Modified Release In Erosive Oesophagitis and Non-Erosive Reflux Disease
    Croxtall, Jamie D.
    Scott, Lesley J.
    DRUGS, 2010, 70 (12) : 1593 - 1601
  • [4] The impact of pre-endoscopy proton pump inhibitor use on the classification of non-erosive reflux disease and erosive oesophagitis
    Gaddam, S.
    Wani, S.
    Ahmed, H.
    Maddur, P.
    Hall, S. B.
    Gupta, N.
    Puli, S. R.
    Higbee, A.
    Rastogi, A.
    Bansal, A.
    Sharma, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (10) : 1266 - 1274
  • [5] Dexlansoprazole Modified ReleaseIn Erosive Oesophagitis and Non-Erosive Reflux Disease
    Jamie D. Croxtall
    Lesley J. Scott
    Drugs, 2010, 70 : 1593 - 1601
  • [6] Partial Symptom Response to Proton Pump Inhibitors in Patients With Non-Erosive Reflux Disease and Reflux Esophagitis
    Bytzer, Peter
    Mattsson, Hanna
    Wernersson, Borje
    GASTROENTEROLOGY, 2011, 140 (05) : S583 - S583
  • [7] The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea
    Kim, N.
    Lee, S. W.
    Choi, S. I.
    Park, C. G.
    Yang, C. H.
    Kim, H. S.
    Rew, J. S.
    Moon, J. S.
    Kim, S.
    Park, S. H.
    Jung, H. C.
    Chung, I. S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (02) : 173 - 185
  • [8] Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients
    Bytzer, P.
    van Zanten, S. Veldhuyzen
    Mattsson, H.
    Wernersson, B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (07) : 635 - 643
  • [9] Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end!
    Scarpignato, C.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 (08): : 697 - 704
  • [10] A comparison of clinical, demographic, and endoscopic findings among patients with erosive and non-erosive reflux disease
    Wani, Sachin
    Bansal, Ajay
    Maddur, Priya
    Hall, Sandi
    Puli, Srinivas R.
    Rastogi, Amit
    Higbee, April
    Sharma, Prateek
    GASTROENTEROLOGY, 2006, 130 (04) : A173 - A174